Evaluation of 'clinical-ready' agents (bazedoxifene and lapatinib) in combination for the prevention of ER+ and ER- mammary cancerspop 6/19/2017 - 6/18/2019
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $681,826
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $681,826.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35233, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$85,736 | |
| Other Administrative Action | $0 | |
| Original award | $767,562 |
About this award
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a firm-fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for the evaluation of "clinical-ready" agents (bazedoxifene and lapatinib) in combination for the prevention of estrogen receptor-positive and estrogen receptor-negative mammary cancers. The contract, which is part of the Preclinical Prevent Cancer Program, has a potential value of $681,826.00 and a period of performance from June 19, 2017 to June 18, 2019, with a completion date of April 30, 2020. UAB is a public research university known for its innovative and interdisciplinary approach to education, and has provided various goods and services to the federal government through prime and sub federal contract awards, including research, engineering, and mission integration services in support of the International Space Station Program.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on June 19, 2017.
How much is contract HHSN26100005 worth?
The government has obligated $681,826 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award